Respiratory syncytial virus infection influences tight junction integrity

Respiratory syncytial virus (RSV) is an important risk factor of asthma development and is responsible for severe respiratory tract infections. However, the influence of RSV infection on barrier function of bronchial epithelial cells in vitro and in vivo is still unclear. The aim of this study was to analyse the role of RSV in tight junction (TJ) regulation and to compare epithelial integrity between asthmatic and healthy individuals upon RSV infection. Healthy and asthmatic human bronchial epithelial cells (HBECs) were differentiated at air–liquid interface (ALI) and infected with RSV and ultraviolet (UV)‐irradiated RSV. TJ expression and their integrity were analysed by quantitative polymerase chain reaction (qPCR), transepithelial resistance (TER) and paracellular flux. To determine the effect in vivo, BALB/c mice were infected intranasally with RSV or UV‐irradiated RSV A2. Bronchoalveolar lavage and TJ integrity were analysed on days 1, 2, 4 and 6 post‐infection by qPCR, bioplex and confocal microscopy. RSV increased barrier integrity in ALI cultures of HBEC from healthy subjects, but no effect was found in HBECs from asthmatics. This was not associated with an increase in TJ mRNA expression. In vivo, RSV induced lung inflammation in mice and down‐regulated claudin‐1 and occludin mRNA expression in whole lungs. Surprisingly, RSV infection was not observed in bronchial epithelial cells, but was found in the lung parenchyma. Decreased expression of occludin upon RSV infection was visible in mouse bronchial epithelial cells in confocal microscopy. However, there was no regulation of claudin‐1 and claudin‐7 at protein level.

[1]  J. Shelhamer,et al.  Dysregulation of lipidomic profile and antiviral immunity in response to hyaluronan in patients with severe asthma. , 2017, The Journal of allergy and clinical immunology.

[2]  G. Taylor.  Animal models of respiratory syncytial virus infection , 2017, Vaccine.

[3]  M. Jarzębska,et al.  Impaired virus replication and decreased innate immune responses to viral infections in nasal epithelial cells from patients with allergic rhinitis , 2017, Clinical and experimental immunology.

[4]  M. Idzko,et al.  Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients , 2017, The Journal of allergy and clinical immunology.

[5]  J. Fahy,et al.  Claudin‐18 deficiency is associated with airway epithelial barrier dysfunction and asthma , 2017, The Journal of allergy and clinical immunology.

[6]  S. Johnston,et al.  Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons , 2015, The Journal of allergy and clinical immunology.

[7]  J. Devincenzo,et al.  Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis , 2014, The Journal of pathology.

[8]  B. Toelle,et al.  Rhinoviruses significantly affect day-to-day respiratory symptoms of children with asthma , 2014, Journal of Allergy and Clinical Immunology.

[9]  G. van Amerongen,et al.  Recombinant Subgroup B Human Respiratory Syncytial Virus Expressing Enhanced Green Fluorescent Protein Efficiently Replicates in Primary Human Cells and Is Virulent in Cotton Rats , 2014, Journal of Virology.

[10]  M. Castro,et al.  Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. , 2014, The Journal of allergy and clinical immunology.

[11]  P. Openshaw,et al.  Immunity to RSV in Early-Life , 2014, Front. Immunol..

[12]  S. Georas,et al.  Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. , 2014, The Journal of allergy and clinical immunology.

[13]  S. Johnston,et al.  Rhinovirus-induced interferon production is not deficient in well controlled asthma , 2013, Thorax.

[14]  S. Georas,et al.  Sustained Protein Kinase D Activation Mediates Respiratory Syncytial Virus-Induced Airway Barrier Disruption , 2013, Journal of Virology.

[15]  Eileen M. Walsh,et al.  Risk of childhood asthma following infant bronchiolitis during the respiratory syncytial virus season. , 2013, The Journal of allergy and clinical immunology.

[16]  C. Akdis,et al.  Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. , 2012, The Journal of allergy and clinical immunology.

[17]  C. Akdis,et al.  The broad spectrum of interepithelial junctions in skin and lung. , 2012, The Journal of allergy and clinical immunology.

[18]  J. Schulzke,et al.  Perspectives on tight junction research , 2012, Annals of the New York Academy of Sciences.

[19]  P. Howarth,et al.  Defective epithelial barrier function in asthma. , 2011, The Journal of allergy and clinical immunology.

[20]  R. Smyth,et al.  Primary airway epithelial cultures from children are highly permissive to respiratory syncytial virus infection , 2011, Thorax.

[21]  H. Tsutsumi,et al.  A nuclear factor-κB signaling pathway via protein kinase C δ regulates replication of respiratory syncytial virus in polarized normal human nasal epithelial cells , 2011, Molecular biology of the cell.

[22]  C. Akdis,et al.  Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects. , 2011, The Journal of allergy and clinical immunology.

[23]  T. Beaty,et al.  Tight junction defects in patients with atopic dermatitis. , 2011, The Journal of allergy and clinical immunology.

[24]  H. Tsutsumi,et al.  Respiratory syncytial virus infection and the tight junctions of nasal epithelial cells. , 2011, Advances in oto-rhino-laryngology.

[25]  M. Sokolowska,et al.  Cytosolic phospholipase A2 group IVA is overexpressed in patients with persistent asthma and regulated by the promoter microsatellites. , 2010, The Journal of allergy and clinical immunology.

[26]  R. Tripp,et al.  Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells. , 2010, The Journal of infectious diseases.

[27]  M. Furuse.  Molecular basis of the core structure of tight junctions. , 2010, Cold Spring Harbor perspectives in biology.

[28]  J. Schwarze.  Lung Dendritic Cells in Respiratory Syncytial Virus Bronchiolitis , 2008, The Pediatric infectious disease journal.

[29]  J. Schwarze,et al.  Respiratory syncytial virus infection provokes airway remodelling in allergen‐exposed mice in absence of prior allergen sensitization , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[30]  Takashi Kojima,et al.  Transmembrane proteins of tight junctions. , 2008, Biochimica et biophysica acta.

[31]  H. Hoogsteden,et al.  Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. , 2008, Canadian journal of physiology and pharmacology.

[32]  S. Holgate.  Epithelium dysfunction in asthma. , 2007, The Journal of allergy and clinical immunology.

[33]  H. Togari,et al.  IL-10 and RANTES are elevated in nasopharyngeal secretions of children with respiratory syncytial virus infection. , 2007, Allergology international : official journal of the Japanese Society of Allergology.

[34]  B. Graham,et al.  The histopathology of fatal untreated human respiratory syncytial virus infection , 2007, Modern Pathology.

[35]  S. Johnston,et al.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.

[36]  R. Tripp,et al.  Cytokines and respiratory syncytial virus infection. , 2005, Proceedings of the American Thoracic Society.

[37]  N. Lukacs,et al.  Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. , 2004, The Journal of infectious diseases.

[38]  Thomas D. Schmittgen,et al.  Real-Time Quantitative PCR , 2002 .

[39]  M. Mäkelä,et al.  Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes. , 1999, Journal of immunology.

[40]  P. Renzi,et al.  Reduced Interferon- γ Production in Infants with Bronchiolitis and Asthma , 1999 .

[41]  P. Renzi,et al.  Reduced interferon-gamma production in infants with bronchiolitis and asthma. , 1999, American journal of respiratory and critical care medicine.

[42]  E. Gelfand,et al.  Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. , 1997, The Journal of clinical investigation.

[43]  M. Perkins,et al.  Primary respiratory syncytial virus infection in mice , 1988, Journal of medical virology.

[44]  G. B. West,et al.  British Society for Immunology , 1957 .